Get the Stockscreener App
6.49
1.67%
-0.11
Capsovision Inc stock is traded at $6.49, with a volume of 70,412.
It is down -1.67% in the last 24 hours and down -8.46% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
See More
Previous Close:
$6.60
Open:
$6.65
24h Volume:
70,412
Relative Volume:
0.47
Market Cap:
$324.26M
Revenue:
$13.56M
Net Income/Loss:
$-26.97M
P/E Ratio:
-11.30
EPS:
-0.5742
Net Cash Flow:
$-24.04M
1W Performance:
-3.28%
1M Performance:
-8.46%
6M Performance:
+8.17%
1Y Performance:
+51.99%
1-Day Range:
$6.40
$6.765
1-Week Range:
$6.40
$7.12
52-Week Range:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.49 | 324.26M | 13.56M | -26.97M | -24.04M | -0.5742 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
Form 4 CapsoVision Inc For: 21 July By Investing.com - Investing.com Canada
CapsoVision director Eliyahou Harari buys $410k in company stock - Investing.com
CapsoVision director Eliyahou Harari buys $410k in company stock By Investing.com - Investing.com Nigeria
CapsoVision 10% owner Eliyahou Harari reports purchase of 61,068 common shares for $410,987.64 - Bitget
U.S. Smart Pills Market to Reach US$ 619.10 Million by 2033 as - openPR.com
CapsoVision (CV) AGM 2026 Summary - Quartr
CapsoVision Inc. (CV) Surges 3.81% as Shares Test Key Resistance LevelsEMA Signal - dars.gov.et
Form 4 CapsoVision Inc For: 10 July By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock - Investing.com
Insider Buyers Lose US$22k As CapsoVision Sheds US$75m - simplywall.st
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock By Investing.com - Investing.com Australia
Form 4 CapsoVision Inc For: 7 July By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock - Investing.com
CapsoVision appoints gastroenterologist David Shields to board - Investing.com
CapsoVision adds Shields to board, refines clinical focus - TipRanks
CapsoVision appoints gastroenterologist David Shields to board By Investing.com - Investing.com Canada
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors - The Manila Times
Director at CapsoVision (CV) awarded 1,710 RSUs vesting in 2026 - Stock Titan
CapsoVision director Joanne Imperial sells $8,586 in common stock By Investing.com - Investing.com Australia
CapsoVision director Joanne Imperial sells $8,586 in common stock - Investing.com
Form 4 CapsoVision Inc For: 1 July By Investing.com - Investing.com Canada
Director Tsai Chen Lung adds CapsoVision (CV) shares via RSU vesting - Stock Titan
CapsoVision (CV) director converts RSUs into 2,022 common shares in equity grant vesting - Stock Titan
CapsoVision, Inc.(NasdaqCM:CV) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 3000E Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 3000 Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 2000 Value Benchmark - marketscreener.com
Here's Why We're Watching CapsoVision's (NASDAQ:CV) Cash Burn Situation - Moomoo
CapsoVision, Inc. Actuals & Estimates (NASDAQ:CV) - TradingView
CapsoVision, Inc. Actuals & Estimates (DUS:H6U) - TradingView
CV Forecast — Price Target — Prediction for 2027 - TradingView
H6U Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of CapsoVision, Inc. – NASDAQ:CV - TradingView
Price to sales forward of CapsoVision, Inc. – NASDAQ:CV - TradingView
CapsoVision, Inc. (CV) Stock Live Price, Chart & News - CoinCodex
CapsoVision Inc (CV) Valuation: PE, PB & Fair Value Analysis - TradingKey
CapsoVision Inc (CV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CapsoVision Inc. (CV) Edges Higher, Testing Key Resistance LevelsPrice Action Signals - DonanımHaber
CV Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 1.69%Full Year Guidance - dars.gov.et
CapsoVision Inc (CV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CapsoVision Inc. (CV) Edges Higher Amid Cautious Trading; Key Levels Define Near-Term PathDynamic Hedging - dars.gov.et
CapsoVision prices $27.5M IPO - MSN
CapsoVision Inc (CV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CapsoVision Inc (CV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CapsoVision Inc (CV) Institutional Confidence - TradingKey
CapsoVision (CV) Holds Steady Near Key Support Amid Low VolatilityBullish Pattern Stocks - dars.gov.et
CapsoVision Inc (CV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CapsoVision Inc (CV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CapsoVision Inc (CV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Capsovision Inc Stock (CV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Capsovision Inc Stock (CV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HARARI ELIYAHOU ET AL | 10% Owner |
Jul 08 '26 |
Buy |
6.09 |
81,300 |
495,117 |
3,282,051 |
| HARARI ELIYAHOU ET AL | 10% Owner |
Jun 26 '26 |
Buy |
7.35 |
13,850 |
101,811 |
3,200,751 |
| Imperial Joanne Carol | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
3,709 |
| Tsai Chen Lung | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
4,929 |
| Kuo Hui Ying | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
15,263 |
| King Wen-Herng Henry | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
25,619 |
| Harari Michele | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
61,065 |
| GOUW JULIA S | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
4,909 |
| Atkinson Douglas Patrick | Head of Global Sales |
May 04 '26 |
Option Exercise |
0.34 |
72,571 |
25,000 |
72,571 |
| Atkinson Douglas Patrick | Head of Global Sales |
May 05 '26 |
Option Exercise |
0.57 |
34,786 |
19,692 |
107,357 |
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):